Related references
Note: Only part of the references are listed.Novel pharmacological modulation of dystonic phenotypes caused by a gain-of-function mutation in the Na+leak-current channel
Merve Kasap et al.
BEHAVIOURAL PHARMACOLOGY (2020)
Mutation of a single residue promotes gating of vertebrate and invertebrate two-pore domain potassium channels
Ismail Ben Soussia et al.
NATURE COMMUNICATIONS (2019)
NALCN channelopathies: Distinguishing gain-of-function and loss-of-function mutations
Eric G. Bend et al.
NEUROLOGY (2016)
Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease
Zahi Qamhawi et al.
BRAIN (2015)
Different sites of alcohol action in the NMDA receptor GluN2A and GluN2B subunits
Yulin Zhao et al.
NEUROPHARMACOLOGY (2015)
K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac
Yin Yao Dong et al.
SCIENCE (2015)
Gain-of-function mutation in TASK-4 channels and severe cardiac conduction disorder
Corinna Friedrich et al.
EMBO MOLECULAR MEDICINE (2014)
Identification of novel small molecule modulators of K2P18.1 two-pore potassium channel
J. Kyle Bruner et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Efficient Marker-Free Recovery of Custom Genetic Modifications with CRISPR/Cas9 in Caenorhabditis elegans
Joshua A. Arribere et al.
GENETICS (2014)
Genetic variation in the two-pore domain potassium channel, TASK-1, may contribute to an atrial substrate for arrhythmogenesis
Bo Liang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
4-Aminopyridine improves freezing of gait in Parkinson's disease
Corneliu C. Luca et al.
JOURNAL OF NEUROLOGY (2013)
Clozapine and Lithium Require Caenorhabditis elegans β-Arrestin and Serum- and Glucocorticoid-Inducible Kinase To Affect DAF-16 (FOXO) Localization
Kathrine R. Weeks et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Inhibition of G Protein-Activated Inwardly Rectifying K+ Channels by Different Classes of Antidepressants
Toru Kobayashi et al.
PLOS ONE (2011)
Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability
Marios Politis et al.
THESCIENTIFICWORLDJOURNAL (2011)
Antipsychotic Drugs Activate the C. elegans Akt Pathway via the DAF-2 Insulin/IGF-1 Receptor
Kathrine R. Weeks et al.
ACS CHEMICAL NEUROSCIENCE (2010)
A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura
Ronald G. Lafreniere et al.
NATURE MEDICINE (2010)
Molecular Background of Leak K+ Currents: Two-Pore Domain Potassium Channels
Peter Enyedi et al.
PHYSIOLOGICAL REVIEWS (2010)
TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system
Stefan Bittner et al.
BRAIN (2009)
Clozapine Interaction with Phosphatidyl Inositol 3-Kinase (PI3K)/Insulin-Signaling Pathway in Caenorhabditis elegans
Rakesh Karmacharya et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Behavioral adaptation in C. elegans produced by antipsychotic drugs requires serotonin and is associated with calcium signaling and calcineurin inhibition
Dallas R. Donohoe et al.
NEUROSCIENCE RESEARCH (2009)
A comparison of the effects of ivermectin and moxidectin on the nematode Caenorhabditis elegans
Bernadette F. Ardelli et al.
VETERINARY PARASITOLOGY (2009)
Maternally inherited Birk barel mental retardation dysmorphism syndrome caused by a mutation in the genomically imprinted potassium channel KCNK9
Ortal Barel et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Pharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans
Gawain McColl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Are Caenorhabditis elegans receptors useful targets for drug discovery:: Pharmacological comparison of tyramine receptors with high identity from C-elegans (TYRA-2) and Brugia malayi (Bm4)
Katherine A. Smith et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2007)
Guidelines on nicotine dose selection for in vivo research
Shannon G. Matta et al.
PSYCHOPHARMACOLOGY (2007)
Cell-specific microarray profiling experiments reveal a comprehensive picture of gene expression in the C-elegans nervous system
Stephen E. Von Stetina et al.
GENOME BIOLOGY (2007)
The neuronal background K-2P channels: focus on TREK1
Eric Honore
NATURE REVIEWS NEUROSCIENCE (2007)
Blockade of HERG human K+ channels and I-Kr of guinea-pig cardiomyocytes by the antipsychotic drug clozapine
So-Young Lee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Antipsychotic drugs disrupt normal development in Caenorhabditis elegans via additional mechanisms besides dopamine and serotonin receptors
Dallas R. Donohoe et al.
PHARMACOLOGICAL RESEARCH (2006)
Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine
LE Kennard et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
SER-7b, a constitutively active Gas coupled 5-HT7-like receptor expressed in the Caenorhabditis elegans M4 pharyngeal motorneuron
RJ Hobson et al.
JOURNAL OF NEUROCHEMISTRY (2003)
An intracellular proton sensor commands lipid- and mechano-gating of the K+ channel TREK-1
E Honoré et al.
EMBO JOURNAL (2002)
Properties and modulation of mammalian 2P domain K+ channels
AJ Patel et al.
TRENDS IN NEUROSCIENCES (2001)
Evolution tunes the excitability of individual neurons
L Salkoff et al.
NEUROSCIENCE (2001)
C-elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway
ER Sawin et al.
NEURON (2000)
TREK-1 is a heat-activated background K+ channel
F Maingret et al.
EMBO JOURNAL (2000)
Share Paper
